1st ProCAncer-I Project Dissemination Event in Vienna

An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum: In Europe, prostate cancer (PC) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices lead to overdiagnosis and overtreatment, necessitating more effective tools for discriminating between aggressive and non-aggressive disease. The EU-funded ProCAncer-I project proposes to develop advanced artificial intelligence models to address unmet clinical needs: diagnosis, metastases detection and prediction of response to treatment. To achieve this, partners will generate a large interoperable repository of health images, and a scalable high-performance computing platform hosting the largest collection of PC Magnetic Resonance Images used for developing robust PC AI models. To ensure the rapid clinical implementation of the models developed, the project’s partners will robustly monitor performance, accuracy and reproducibility. 

Welcome by Coordinating Team

We are very glad to lead a very ambitious and health-driven project that could end to alleviating and helping thousands of men to tackle prostate cancer in a more personalized way supporting a better quality of life

The Coordinating Team

Manolis Tsiknakis

Prof. Manolis Tsiknakis
(Coordinator)

Dr. Nikolaos Papanikolaou
(Scientific Manager)

Prof. Kostas Marias
(Technical Manager)

Prof. Daniele Regge
(Clinical Manager)

The ProCAncer-I project is one of the founding projects of the FUTURE-AI.

FUTURE-AI is an international, multi-stakeholder initiative for defining and maintaining concrete guidelines that will facilitate the design, development, validation, and deployment of trustworthy AI solutions in medical imaging based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability.

Project Information

Months (Duration)

Euros (Total Budget )

Grant Agreement Nr.

Funded

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

|

Topic

DT-TDS-05-2020:
AI for Health Imaging

Highlights

ProCAncer-I in the IEEE-MeMeA Conference in Taormina

ProCAncer-I in the IEEE-MeMeA Conference in Taormina

We are looking forward to participating it the upcoming IEEE-MeMeA Conference in Taormina! The 17th edition of IEEE International Symposium on Medical Measurements and Applications will take place in Giardini Naxos, Taormina in the metropolitan area of Messina,...

Diagnosing Prostate Cancer with Artificial Intelligence? https://www.emjreviews.com/innovations/news/diagnosing-prostate-cancer-with-artificial-intelligence/#.YvIwkwfkc-0.twitter

📢Save the date!
The ProCAncer-I Consortium together with the other #AI4HI funded projects are organising a workshop at the IEEE BHI-BSN Conference 2022 in Ioannina! https://bit.ly/3OVF21y
@EuCanImage @IncisiveEu @primage_project @chaimeleon_eu #H2020 @EU_H2020 @ProCAncer_I

An absolute pleasure to be part of the ECR in #Vienna! The ProCAncer-I project team presented the vision of the project at a special session. Really good to connect with everyone again face to face!
@myESR

Read more➡️https://bit.ly/3veUvTq
#AI #prostatecancer #h2020

4

New event in Ioannina, Greece🗓️ We have co-organized together with the AI4HI funded projects the workshop ‘Developing open, standard-based, interoperable Cancer Imaging Repositories in Europe: Issues, Experiences and Challenges’. 👉
https://incisive-project.eu/event/ieee-bhi-bsn-conference-2/

📢 Happening today! 🥳
Don't miss our Special Session at the #ECR2022!
📍Vienna
https://connect.myesr.org/course/building-bridges-from-radiomics-ai-research-to-clinical-practice-the-procancer-i-vision/
.
.
.
@myESR #radiology #imaging #medicalimaging #vienna #austria #AI #radiology #healthcare #technology

Load More...

Stay in touch!